The current issue with GERN and Imetelstat is the publication of their Path Forward.
There are plenty of questions and few answers right now.
There is also lots of additional human testing before Imetelstat is approved to market.
I find it very troubling that our PPS has been jerked all over the place. Yes, we've seen this type of activity before and, no, we don't know if it's legal or not. The MMs have great latitude in their ability to make stock trades. We should all know that. We should all also know that the SEC is charges with policing many of the Market activities.
I am also troubled that this type of activity will continue with GERN stock unless/ until some action is taken. Hairy mentioned, yesterday, that he was going to submit a SEC Complaint but didn't have all the necessary information to do it.
So, what to do????
I'll offer a few ideas with the notion that others will add to the list.
1. We have some board members who have worked in Market activities over the years. Some have many years of experience. Maybe they could tell us exactly who the MMs are who trade GERN stock and how to contact them?
2. Maybe these same members can suggest questions that we can formally or informally ask these MMs about GERN trading that will give us some insight to the trading over the past several months?
3. Anna told 77 that GERN did NOT sell any shares. I don't want to suggest that Anna mislead 77, or, that 77 misunderstood Anna, but lets wait before taking any action with the SEC until we see the next formal financial report. These Quarterlys/ Annuals are signed by the company executives and carry the full force of law. Perhaps this next report could be used as one basis for a SEC complaint? If GERN didn't sell, what happened?
4. Complaints with requests for action should be sent to chippy and the whole GERN Board of Directors. After all, the PPS effects them too. They should be concerned about the "games" and should be empowered to request a formal SEC inquiry as to the legality of whatever transpired. If chippy is interested in Investor Value, let him find out what is going on and then tell us.
What say the tribe?
Of course, IMO.
Just for a little levity, over on the VRNG board one poster goes by the alias whet_phart and another by shavenkunt2.
77: I saw your comment on the other thread. I'm surprised. Of course, knowing about a board and actively participating or reading are two different things.
I wonder if she knows how I feel about the situation?
77: when commenting to joanie make sure you take a hard look at the character on the far right of the alias.
There are 2 of her. One has a "1" at the far right and the other a "I."
I can't count the times that I've been on and off maine's iggy list.
He really likes it when I post anything about ACTC on this board.
77: thanks for the detailed report of what was discussed.
It's most interesting that GERN didn't sell any shares!!! That's telling us that there have been HUGE games played with the PPS by someone or some organization. Maybe the truth will surface in the near future???
I'm not surprised that she didn't say anything about the dosing cost. I really hope that its in their Product Development Plan. Not only do they need to address this aspect of development in their own efforts, any prospective buyers will want to examine this facet of drug development
I'm going to "back off" on the criticism for a while. I'll wait and see what else transpires.
I'm going to re-read your posts to make sure that I didn't miss anything.
Once again a big THANKS!!!
box: people come up with all sorts of aliases on these boards.
I just don't think that you can deduce anything much about their alias.
Some of the aliases are cute, some stupid, and some obnoxious!
Take your pick!
It's dangerous to play options and set stops on a stock like GERN where it's obvious that games are being played!!!!
Of course, IMO
77: that sort of information WILL BE in any credible product development plan. I have been very critical of GERN management because I just don't think that they have the expertise or skill sets required to bring a product to market. It's not an easy job and takes lots of planning. If you haven't been part of the process before, you are likely to FAIL.
Whether they have developed such a plan or whether they will disclose that information are other questions.
box: yes, I agree with you.
But, these are the types of questions that should be brought before GERN management and they should begin giving the investment community some data.
I'm hoping that Anna may provide some feedback to chippy.
I know that it's a long shot, but Hail Mary's do work every once in a while!